Cytosorbents CORP 8-K Filing
Ticker: CTSO · Form: 8-K · Filed: Apr 2, 2026 · CIK: 0001175151
| Field | Detail |
|---|---|
| Company | Cytosorbents CORP (CTSO) |
| Form Type | 8-K |
| Filed Date | Apr 2, 2026 |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $1.00 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Cytosorbents CORP (ticker: CTSO) to the SEC on Apr 2, 2026.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (nge on which registered Common Stock, $0.001 par value CTSO The NASDAQ Stock Marke); $1.00 (ment to maintain a minimum bid price of $1.00 per share for continued listing on Nasd).
How long is this filing?
Cytosorbents CORP's 8-K filing is 2 pages with approximately 729 words. Estimated reading time is 3 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 729 words · 3 min read · ~2 pages · Grade level 13 · Accepted 2026-04-02 07:00:20
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value CTSO The NASDAQ Stock Marke
- $1.00 — ment to maintain a minimum bid price of $1.00 per share for continued listing on Nasd
Filing Documents
- tm2611004d1_8k.htm (8-K) — 25KB
- 0001104659-26-038859.txt ( ) — 185KB
- ctso-20260401.xsd (EX-101.SCH) — 3KB
- ctso-20260401_lab.xml (EX-101.LAB) — 33KB
- ctso-20260401_pre.xml (EX-101.PRE) — 22KB
- tm2611004d1_8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: April 2, 2026 CYTOSORBENTS CORPORATION By: /s/ Dr. Phillip P. Chan Name: Dr. Phillip P. Chan Title: Chief Executive Officer